Cargando…
NK cells protect TCR-transgenic mice from developing fetal leukemia
Autores principales: | Dubois, Sigrid, Müller, Jürgen, Feigenbaum, Lionel, Waldmann, Thomas A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288549/ http://dx.doi.org/10.1186/2051-1426-2-S3-P167 |
Ejemplares similares
-
Leukemia/lymphoma development in IL-15-deficient TCR-transgenic mice
por: Dubois, Sigrid, et al.
Publicado: (2015) -
P69. Targeting naturally presented, leukemia-derived HLA ligands with TCR-transgenic T cells for the treatment of therapy refractory leukemias
por: Richard, K, et al.
Publicado: (2014) -
Loss of Cytotoxicity and Gain of Cytokine Production in Murine Tumor-Activated NK Cells
por: Müller, Jürgen R., et al.
Publicado: (2014) -
Engagement of lymphoma T cell receptors causes accelerated growth and the secretion of an NK cell-inhibitory factor
por: Dubois, Sigrid, et al.
Publicado: (2020) -
Lymph act, TCR αβ, TCR γδ cells in peripheral blood in children with juvenile idiopathic arthritis
por: Mazur-Zielinska, H
Publicado: (2008)